Differential Regulation of Native Estrogen Receptor-Regulatory Elements by Estradiol, Tamoxifen, and Raloxifene

Published on Feb 1, 2008in Molecular Endocrinology3.628
· DOI :10.1210/ME.2007-0340
Nitzan Levy6
Estimated H-index: 6
(UCSF: University of California, San Francisco),
Dierdre Tatomer1
Estimated H-index: 1
(UCSF: University of California, San Francisco)
+ 7 AuthorsDale C. Leitman26
Estimated H-index: 26
Sources
Abstract
Estrogen receptors (ERs) regulate gene transcription by interacting with regulatory elements. Most information regarding how ER activates genes has come from studies using a small set of target genes or simple consensus sequences such as estrogen response element, activator protein 1, and Sp1 elements. However, these elements cannot explain the differences in gene regulation patterns and clinical effects observed with estradiol (E2) and selective estrogen receptor modulators. To obtain a greater understanding of how E2 and selective estrogen receptor modulators differentially regulate genes, it is necessary to investigate their action on a more comprehensive set of native regulatory elements derived from ER target genes. Here we used chromatin immunoprecipitation-cloning and sequencing to isolate 173 regulatory elements associated with ERα. Most elements were found in the introns (38%) and regions greater than 10 kb upstream of the transcription initiation site (38%); 24% of the elements were found in the...
📖 Papers frequently viewed together
272 Citations
728 Citations
330 Citations
References51
Newest
#1Nitzan Levy (UCSF: University of California, San Francisco)H-Index: 6
#2Xiaoyue Zhao (University of California, Berkeley)H-Index: 9
Last. Dale C. Leitman (UCSF: University of California, San Francisco)H-Index: 26
view all 6 authors...
Estrogen receptors (ERs) regulate transcription by interacting with regulatory elements in target genes. However, known ER regulatory elements cannot explain the expression profiles of genes activated by estradiol (E2) and selective estrogen receptor modulators (SERMs). We previously showed that the killer cell lectin-like receptor (NKG2E) gene is regulated by E2, tamoxifen, and raloxifene. Here we used the NKG2E gene as a model to investigate the mechanism whereby target genes are regulated by ...
27 CitationsSource
#1Alex Yick-Lun So (UCSF: University of California, San Francisco)H-Index: 17
#2Christina Chaivorapol (UCSF: University of California, San Francisco)H-Index: 5
Last. Keith R. Yamamoto (UCSF: University of California, San Francisco)H-Index: 82
view all 5 authors...
The glucocorticoid receptor (GR) associates with glucocorticoid response elements (GREs) and regulates selective gene transcription in a cell-specific manner. Native GREs are typically thought to be composite elements that recruit GR as well as other regulatory factors into functional complexes. We assessed whether GR occupancy is commonly a limiting determinant of GRE function as well as the extent to which core GR binding sequences and GRE architecture are conserved at functional loci. We surv...
304 CitationsSource
#1Zhihong Lin (NU: Northwestern University)H-Index: 22
#2Scott Reierstad (NU: Northwestern University)H-Index: 22
Last. Serdar E. BulunH-Index: 73
view all 4 authors...
Estrogen receptor-α (ERα) and its ligand estradiol play critical roles in breast cancer growth and are important therapeutic targets for this disease. Using chromatin immunoprecipitation (ChIP)-on-chip, ligand-bound ERα was recently found to function as a master transcriptional regulator via binding to many cis -acting sites genome-wide. Here, we used an alternative technology (ChIP cloning) and identified 94 ERα target loci in breast cancer cells. The ERα-binding sites contained both classic es...
107 CitationsSource
The selective estrogen receptor modulator (SERM) tamoxifen has long been used to treat both early and advanced breast cancer. Raloxifene is a second-generation SERM that, in addition to combatting osteoporosis, may also lessen the risk of invasive breast cancer in postmenopausal women; The National Surgical Adjuvant Breast and Bowel Project (NSABP) Study of Tamoxifen and Raloxifene (STAR) is a prospective, randomized, double-blind trial conducted at nearly 200 clinical centers throughout North A...
61 CitationsSource
#1Jason S. Carroll (Harvard University)H-Index: 56
#2Clifford A. Meyer (Harvard University)H-Index: 40
Last. Myles Brown (Harvard University)H-Index: 98
view all 18 authors...
The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and the archetype of a molecular therapeutic target. We mapped all estrogen receptor and RNA polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding sites and target genes, in breast cancer cells. Combining this unique resource with gene expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene regulation, particularly in the case of estrogen-suppre...
1,437 CitationsSource
#1Victor G. Vogel (University of Pittsburgh)H-Index: 45
#2Joseph P. Costantino (University of Pittsburgh)H-Index: 72
Last. Norman Wolmark (Allegheny General Hospital)H-Index: 16
view all 17 authors...
ContextTamoxifen is approved for the reduction of breast cancer risk, and raloxifene has demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis.ObjectiveTo compare the relative effects and safety of raloxifene and tamoxifen on the risk of developing invasive breast cancer and other disease outcomes.Design, Setting, and PatientsThe National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial, a prospective, double-blind, randomized c...
1,881 CitationsSource
#1George Christodoulakos (UoA: National and Kapodistrian University of Athens)H-Index: 20
#2Dimitrios Botsis (UoA: National and Kapodistrian University of Athens)H-Index: 18
Last. George Creatsas (UoA: National and Kapodistrian University of Athens)H-Index: 34
view all 10 authors...
Abstract Objectives To study the effect of standard and low-dose estrogen–progestin therapy (EPT), tibolone and raloxifene on the incidence of vaginal spotting/bleeding and endometrial thickness over a 5-year period. Methods Seven hundred eighty-six postmenopausal women were studied in an open prospective design. Vaginal spotting/bleeding and endometrial thickness as assessed by transvaginal ultrasonography was compared between six categories of women over a 5-year period: three categories in wo...
53 CitationsSource
#1Josée Laganière (MUHC: McGill University Health Centre)H-Index: 9
#2Geneviève DebloisH-Index: 17
Last. Vincent GiguèreH-Index: 76
view all 6 authors...
Nuclear receptors can activate diverse biological pathways within a target cell in response to their cognate ligands, but how this compartmentalization is achieved at the level of gene regulation is poorly understood. We used a genome-wide analysis of promoter occupancy by the estrogen receptor α (ERα) in MCF-7 cells to investigate the molecular mechanisms underlying the action of 17β-estradiol (E2) in controlling the growth of breast cancer cells. We identified 153 promoters bound by ERα in the...
497 CitationsSource
#1Jason S. Carroll (Harvard University)H-Index: 56
#2X. Shirley Liu (Harvard University)H-Index: 81
Last. Myles Brown (Harvard University)H-Index: 98
view all 13 authors...
Estrogen plays an essential physiologic role in reproduction and a pathologic one in breast cancer. The completion of the human genome has allowed the identification of the expressed regions of protein-coding genes; however, little is known concerning the organization of their cis-regulatory elements. We have mapped the association of the estrogen receptor (ER) with the complete nonrepetitive sequence of human chromosomes 21 and 22 by combining chromatin immunoprecipitation (ChIP) with tiled mic...
1,347 CitationsSource
#1David G. Monroe (UR: University of Rochester)H-Index: 27
#2Frank J. Secreto (UR: University of Rochester)H-Index: 1
Last. Thomas C. Spelsberg (UR: University of Rochester)H-Index: 69
view all 6 authors...
The 17β-estradiol (E2) receptor isoforms [estrogen receptor (ER) α and ERβ] bind E2 and selective ER modulators (SERMs) as homodimers (α/α or β/β) or heterodimers (α/β) to regulate gene expression. Although recent studies have shown that ER homodimers regulate unique sets of E2-responsive genes, little information exists regarding the transcriptional actions of the ERα/β heterodimer. This paper describes the development of a U2OS human osteosarcoma (osteoblast) cell line stably expressing both E...
182 CitationsSource
Cited By53
Newest
#1Shaimaa M. Badr-Eldin (Cairo University)H-Index: 11
#2Hibah M. Aldawsari (KAU: King Abdulaziz University)H-Index: 12
Last. Usama A. Fahmy (KAU: King Abdulaziz University)H-Index: 12
view all 7 authors...
Abstract Raloxifene hydrochloride (RLX) is a selective estrogen receptor modulator used for treatment and protection against postmenopausal osteoporosis. The drug has been used for protection against breast cancer and more recently, for management of the disease by virtue of its estrogen antagonist action. However, the drug has reduced bioavailability related to low water solubility and first pass metabolism. To surmount these pitfalls, this study aimed at developing and optimizing RLX-loaded se...
Source
#1Nora BourbiaH-Index: 1
#2Paige ChandlerH-Index: 1
Last. Patrick M. NolanH-Index: 6
view all 5 authors...
Spermatogenesis-associated protein 13 (Spata13) is a guanine nucleotide exchange factor (GEF) enriched in discrete brain regions in the adult, with pronounced expression in the extended central amygdala (CeA). Loss of Spata13, also known as the adenomatous polyposis coli exchange factor Asef2, has no identifiable phenotype although it has been shown to reduce the number and size of intestinal tumours in Apc (Min/+) mice. Nevertheless, its brain-related functions have not been investigated. To pu...
5 CitationsSource
#1David F. Archer (EVMS: Eastern Virginia Medical School)H-Index: 47
#2Bruce R. CarrH-Index: 58
Last. Ginger D. ConstantineH-Index: 22
view all 5 authors...
Up to 50% of postmenopausal women experience vulvar and vaginal atrophy (VVA), a long-term condition caused by estrogen deficiency that is characterized by histologic vaginal changes such as epithelial thinning, decreased squamous cell maturation, and increased pH; VVA symptoms negatively impact women’s quality of life.1-3 VVA is thought to be a progressive condition that does not resolve without treatment.4 In postmenopausal women, estrogen deficiency also adversely affects other tissues (eg, m...
23 CitationsSource
#1Mark J. Canet (UA: University of Arizona)H-Index: 11
#2Matthew D. Merrell (UA: University of Arizona)H-Index: 8
Last. Nathan J. Cherrington (UA: University of Arizona)H-Index: 42
view all 10 authors...
The ATP-binding cassette (ABC) family of transporters, including ABCC3, is a large family of efflux pumps that plays a pivotal role in the elimination of xenobiotics from the body. ABCC3 has been reported to be induced during hepatic stress conditions and through the progression of some forms of cancer. Several lines of evidence have implicated the transcription factor nuclear factor (erythroid-derived 2)–like 2 (Nrf2) in this induction. However, although rodent models have been investigated, a ...
14 CitationsSource
#1Xuqing Zhang (Janssen Pharmaceutica)H-Index: 1
#2Zhihua Sui (Janssen Pharmaceutica)H-Index: 1
Introduction: The development and potential clinical use of tissue-selective androgen receptor modulators (SARMs) have advanced tremendously over the past few years. A key aspect of SARMs is the ability to clearly differentiate between the anabolic and androgenic activities. SARMs provide therapeutic opportunities in a variety of diseases, including muscle wasting associated with burns, cancer, end-stage renal disease, osteoporosis, frailty and hypogonadism. Areas covered: The aim of the present...
38 CitationsSource
#1Nina D’Abreo (Winthrop-University Hospital)H-Index: 2
#2Alexander A. Hindenburg (SBU: Stony Brook University)H-Index: 3
The dependency of certain breast cancers on estrogen is undeniably one of the most important observations in oncology. Since this early observation, there has been a tremendous effort to define the precise roles of the estrogen receptor (ER) in the pathogenesis of breast cancer. Estrogen signaling pathways can also be exploited as effective targets for cancer treatment. Both ligand-dependent and ligand-independent receptor activation pathways have been successfully blocked by hormonal therapies ...
6 CitationsSource
#1Madryn C. Lake (Imperial College London)H-Index: 2
#2Quang-Dé Nguyen (Imperial College London)H-Index: 32
Last. Eric O. Aboagye (Imperial College London)H-Index: 42
view all 4 authors...
Anti-estrogens, in particular tissue selective anti-estrogens, have been the bedrock of adjuvant therapy for patients with estrogen receptor alpha (ERα) positive breast cancer. Though current therapies have greatly enhanced patient prognosis, there continues to be an impetus for the development of improved anti-estrogens. ERα is a nuclear receptor transcription factor which activates gene expression through the recruitment of transcriptional coactivator proteins. The SRC family of coactivators, ...
7 CitationsSource
#1Hui Li (CPU: China Pharmaceutical University)H-Index: 3
#2Zhenzhen Tu (CPU: China Pharmaceutical University)H-Index: 4
Last. Yueqing Gu (CPU: China Pharmaceutical University)H-Index: 31
view all 6 authors...
Context: Estrogen is well-known as an important factor in the physiological functions and pathological processes of breast. Estrogen receptor β (ERβ) is expressed in the majority of breast cancers at lower levels compared with the normal breast tissue.Objective: The effect of ERβ on the characteristics of breast tumor cells and its prognostication for the use of ERβ-selective therapy were investigated here for the first time.Materials and methods: ERβ was overexpressed in ERα positive MCF-7 brea...
12 CitationsSource
#1Yuet-Kin Leung (UC: University of Cincinnati)H-Index: 26
#2Ming-Tsung Lee (UC: University of Cincinnati)H-Index: 6
Last. Shuk-Mei HoH-Index: 63
view all 5 authors...
Abstract Estrogen receptor (ER) β was discovered over a decade ago. The design of most studies on this receptor was based on knowledge of its predecessor, ERα. Although breast cancer (BCa) has been a main focus of ERβ research, its precise roles in breast carcinogenesis remain elusive. Data from in vitro models have not always matched those from observational or clinical studies. Several inherent factors may contribute to these discrepancies: (a) several ERβ spliced variants are expressed at the...
49 CitationsSource